Serological aggravation of autoimmune thyroid disease in two cases receiving nivolumab

Journal of Dermatology

Volumn 43, Issue 2, 2016, Pages 210-214

  Narita, Tomohiko ^a   Oiso, Naoki ^a   Taketomo, Yasunori ^a   Okahashi, Kazunori ^a   Yamauchi, Kohei ^a   Sato, Masako ^a   Uchida, Shusuke ^a   Matsuda, Hiromasa ^a   Kawada, Akira ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Hashimoto disease; insulin dependent diabetes; malignant melanoma; nivolumab; ultrasonography; vitiligo

Indexed keywords

BETA INTERFERON; CISPLATIN; DACARBAZINE; LEVOTHYROXINE SODIUM; NIMUSTINE; NIVOLUMAB; POTASSIUM IODIDE; TAMOXIFEN; THYROID EXTRACT; VINCRISTINE; MONOCLONAL ANTIBODY; THYROID HORMONE;

AGED; ARTICLE; BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; ECHOGRAPHY; FEMALE; HASHIMOTO DISEASE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTATIC MELANOMA; BLOOD; DIAGNOSTIC IMAGING; IMMUNOLOGY; SECONDARY; THYROID GLAND;

AGED; ANTIBODIES, MONOCLONAL; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; MELANOMA; THYROID GLAND; THYROID HORMONES; ULTRASONOGRAPHY;

EID: 84956840392     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13028     Document Type: Article

References (8)

1. Topalian SL, Sznol M, McDermott DF, et al,. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol 2014; 32: 1020-1030.
2. Hughes J, Vudattu N, Sznol M, et al,. Precipitation of autoimmune diabetes with Anti-PD-1 immunotherapy. Diabetes Care 2015; 38: e55-e57.
3. Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T,. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int 2011; 60: 505-508.
4. Noso S, Park C, Babaya N, et al,. Organ-specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata. J Clin Endocrinol Metab 2015; 100: 1976-1983.
5. Teulings HE, Overkamp M, Ceylan E, et al,. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol 2013; 168: 162-171.
6. Paradisi A, Tabolli S, Didona B, Sobrino L, Russo N, Abeni D,. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol 2014; 71: 1110-1116.
7. Spritz RA,. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med 2010; 2: 78.
8. Pedoeem A, Azoulay-Alfaguter I, Strazza M, Silverman GJ, Mor A,. Programmed death-1 pathway in cancer and autoimmunity. Clin Immunol 2014; 153: 145-152.